Concord Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 26, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Market Capitalization	177,492	159,100	-	-	-	-
Enterprise Value	174,689	157,079	-	-	-	-
Last Close Price	1695.00	1513.48	-	-	-	-
PE Ratio	54.40	51.64	-	-	-	-
PS Ratio	21.23	15.65	-	-	-	-
PB Ratio	14.54	10.42	-	-	-	-
P/TBV Ratio	14.55	10.42	-	-	-	-
P/FCF Ratio	88.50	-	-	-	-
P/OCF Ratio	59.93	-	-	-	-
EV/Sales Ratio	16.04	15.45	-	-	-	-
EV/EBITDA Ratio	38.28	35.81	-	-	-	-
EV/EBIT Ratio	43.29	40.61	-	-	-	-
EV/FCF Ratio	87.37	-	-	-	-
Debt / Equity Ratio	0.00	0.01	0.02	0.06	0.09	0.07
Debt / EBITDA Ratio	0.01	0.02	0.09	0.22	0.27	0.24
Debt / FCF Ratio	-	0.05	0.31	1.19	-	-
Asset Turnover	-	0.63	0.60	0.57	0.58	-
Inventory Turnover	-	1.17	0.94	0.99	0.88	-
Quick Ratio	-	4.55	2.43	2.71	3.92	3.45
Current Ratio	-	6.31	3.79	4.08	5.74	4.68
Return on Equity (ROE)	-	21.88%	20.06%	16.64%	26.55%	-
Return on Assets (ROA)	-	15.04%	13.26%	11.47%	17.80%	-
Return on Capital (ROIC)	17.06%	16.92%	15.07%	12.70%	19.78%	-
Return on Capital Employed (ROCE)	-	24.80%	22.70%	19.80%	28.10%	23.50%
Earnings Yield	1.84%	1.94%	-	-	-	-
FCF Yield	1.13%	-	-	-	-
Dividend Yield	0.51%	0.58%	-	-	-	-
Payout Ratio	0.00%	23.19%	22.31%	40.31%	2.43%	47.63%
Total Shareholder Return	0.49%	0.58%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.